Janice Mayes

627 total citations
17 papers, 549 citations indexed

About

Janice Mayes is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Janice Mayes has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Janice Mayes's work include Cancer therapeutics and mechanisms (16 papers), Acute Lymphoblastic Leukemia research (8 papers) and Lung Cancer Research Studies (6 papers). Janice Mayes is often cited by papers focused on Cancer therapeutics and mechanisms (16 papers), Acute Lymphoblastic Leukemia research (8 papers) and Lung Cancer Research Studies (6 papers). Janice Mayes collaborates with scholars based in United States and United Kingdom. Janice Mayes's co-authors include Michael Hinds, Leonard A. Zwelling, Elizabeth Altschuler, Diana Chan, Lynn Silberman, Mark Blick, Karl Deisseroth, Fred D. Ledley, Ruud Jansen and Miloslav Beran and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Biochemical Journal.

In The Last Decade

Janice Mayes

17 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janice Mayes United States 10 496 301 82 77 52 17 549
Lynn Silberman United States 12 429 0.9× 199 0.7× 76 0.9× 91 1.2× 31 0.6× 17 498
G A Hofmann United States 7 600 1.2× 336 1.1× 147 1.8× 78 1.0× 60 1.2× 10 657
F L McCabe United States 9 819 1.7× 558 1.9× 188 2.3× 119 1.5× 77 1.5× 14 928
Hellmuth R. Hinz United States 10 506 1.0× 324 1.1× 76 0.9× 42 0.5× 45 0.9× 13 566
Masami Bungo Japan 7 264 0.5× 242 0.8× 39 0.5× 27 0.4× 11 0.2× 10 396
K W Kohn United States 7 325 0.7× 234 0.8× 26 0.3× 30 0.4× 12 0.2× 9 465
Judith A. Besserer United States 8 241 0.5× 122 0.4× 41 0.5× 95 1.2× 8 0.2× 10 397
Glenys M. Otter United States 11 211 0.4× 99 0.3× 32 0.4× 111 1.4× 6 0.1× 24 369
Malini Gupta United States 8 301 0.6× 127 0.4× 48 0.6× 27 0.4× 8 0.2× 14 418
Akira Kiue Japan 13 243 0.5× 254 0.8× 21 0.3× 107 1.4× 7 0.1× 16 453

Countries citing papers authored by Janice Mayes

Since Specialization
Citations

This map shows the geographic impact of Janice Mayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice Mayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice Mayes more than expected).

Fields of papers citing papers by Janice Mayes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice Mayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice Mayes. The network helps show where Janice Mayes may publish in the future.

Co-authorship network of co-authors of Janice Mayes

This figure shows the co-authorship network connecting the top 25 collaborators of Janice Mayes. A scholar is included among the top collaborators of Janice Mayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice Mayes. Janice Mayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Asano, Takeshi, et al.. (1996). Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide. British Journal of Cancer. 73(11). 1373–1380. 16 indexed citations
2.
3.
Ellis, Amy, Elizabeth Altschuler, Elise S. Bales, et al.. (1994). Phorbol regulation of topoisomerases I and II in human leukemia cells. Biochemical Pharmacology. 47(2). 387–396. 4 indexed citations
4.
Mayes, Janice, et al.. (1993). Further characterization of an amsacrine-resistant line of HL-60 human leukemia cells and its topoisomerase II. Biochemical Pharmacology. 46(4). 699–707. 8 indexed citations
5.
6.
Zwelling, Leonard A., et al.. (1993). Activity of two novel anthracene-9,10-diones against human leukemia cells containing intercalator-sensitive or -resistant forms of topoisomerase II. Biochemical Pharmacology. 46(2). 265–271. 18 indexed citations
7.
Mitchell, Michael, et al.. (1992). Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.. PubMed. 52(1). 209–17. 22 indexed citations
8.
Zwelling, Leonard A., Diana Chan, Elizabeth Altschuler, et al.. (1991). Effect of bryostatin 1 on drug-induced, topoisomerase II-mediated DNA cleavage and topoisomerase 11 gene expression in human leukemia cells. Biochemical Pharmacology. 41(5). 829–832. 1 indexed citations
9.
Whelan, Richard D. H., et al.. (1991). A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance. International Journal of Cancer. 47(6). 899–902. 9 indexed citations
10.
Zwelling, Leonard A., Elizabeth Altschuler, Janice Mayes, Michael Hinds, & Diana Chan. (1991). The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Chemotherapy and Pharmacology. 29(1). 48–52. 4 indexed citations
11.
Hinds, Michael, Karl Deisseroth, Janice Mayes, et al.. (1991). Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.. PubMed. 51(17). 4729–31. 126 indexed citations
12.
Zwelling, Leonard A., Janice Mayes, Karl Deisseroth, et al.. (1990). A Restriction Fragment Length Polymorphism for Human Topoisomerase II: Possible Relationship to Drug-Resistance. PubMed. 2(11). 357–361. 8 indexed citations
13.
Zwelling, Leonard A., Marilyn L. Slovak, J. H. Doroshow, et al.. (1990). HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II. JNCI Journal of the National Cancer Institute. 82(19). 1553–1561. 48 indexed citations
14.
Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1990). Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.. PubMed. 50(22). 7116–22. 33 indexed citations
15.
Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1989). Characterization of an Amsacrine-resistant Line of Human Leukemia Cells. Journal of Biological Chemistry. 264(28). 16411–16420. 159 indexed citations
16.
Zwelling, Leonard A., Diana Chan, Michael Hinds, Lynn Silberman, & Janice Mayes. (1988). Anion-dependent modulations of DNA topoisomerase II-mediated reactions in potassium-containing solutions. Biochemical and Biophysical Research Communications. 152(2). 808–817. 8 indexed citations
17.
Zwelling, Leonard A., Diana Chan, Michael Hinds, et al.. (1988). Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.. PubMed. 48(23). 6625–33. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynn Silberman Breakdown of academic impact, for papers by G A Hofmann Breakdown of academic impact, for papers by F L McCabe Breakdown of academic impact, for papers by Hellmuth R. Hinz Breakdown of academic impact, for papers by Masami Bungo Breakdown of academic impact, for papers by K W Kohn Breakdown of academic impact, for papers by Judith A. Besserer Breakdown of academic impact, for papers by Glenys M. Otter Breakdown of academic impact, for papers by Malini Gupta Breakdown of academic impact, for papers by Akira Kiue
Rankless by CCL
2026